Efficacy and Safety of KH903 Plus FOLFIRI as a Second-Line Treatment in Unresectable Recurrent or Metastatic Colorectal Cancer: A Randomized Phase 2 StudyLi J, Rongbo Lin, Jian Xu et al.|Clinical Colorectal Cancer|2024Cited by 0